N-3 fatty acids, γ-linolenic acid, and antioxidants in sepsis

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Das, Undurti N ^a,b,c  

^a UND LIFE SCIENCES   (United States)

^b GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CD59 ANTIGEN; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOXIN; LIPOXIN A; LONG CHAIN FATTY ACID; NITRIC OXIDE; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; AUTACOID; OMEGA 3 FATTY ACID;

ARTICLE; CELL PROTECTION; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID METABOLISM; FLOW CYTOMETRY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; BLOOD; CRITICAL ILLNESS; METABOLISM;

ANTIOXIDANTS; CRITICAL ILLNESS; FATTY ACIDS, OMEGA-3; GAMMA-LINOLENIC ACID; HUMANS; INFLAMMATION MEDIATORS; SEPSIS;

EID: 84876440507     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12574     Document Type: Article

References (27)

1. Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P. Enteral omega-3 fatty acid, γ-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 2011, 306:1574-1581. 10.1001/jama.2011.1435, 21976613.
2. Schott CR, Huang DT. ω-3 fatty acids, γ-linolenic acid, and antioxidants: immunomodulators or inert dietary supplements?. Crit Care 2012, 16:325. 10.1186/cc11863, 23176247.
3. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420. 10.1097/00003246-199908000-00001, 10470743.
4. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333. 10.1097/01.CCM.0000234033.65657.B6, 16850002.
5. Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 2008, 32:596-605. 10.1177/0148607108324203, 18974237.
6. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038. 10.1097/01.CCM.0000206111.23629.0A, 16484911.
7. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G, A.S.P.E.N.Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009, 33:277-316. 10.1177/0148607109335234, 19398613, A.S.P.E.N.Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine.
8. Das UN. Essential fatty acids - a review. Curr Pharm Biotechnol 2006, 7:467-482. 10.2174/138920106779116856, 17168664.
9. Das UN. Essential fatty acids: biochemistry, physiology, and pathology. Biotechnol J 2006, 1:420-439. 10.1002/biot.200600012, 16892270.
10. Kumar SG, Das UN, Kumar KV, Das NP, Tan BKH. Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutr Res 1992, 12:815-823.
11. Kumar SG, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids 1994, 50:331-334. 10.1016/0952-3278(94)90242-9, 7938085.
12. Furse RK, Rossetti RG, Seiler CM, Zurier RB. Oral administration of gamma linolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes. J Clin Immunol 2002, 22:83-91. 10.1023/A:1014479702575, 11998897.
13. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1067-L1082.
14. Trostchansky A, Rubbo H. Nitrated fatty acids: mechanisms of formation, chemical characterization, and biological properties. Free Radic Biol Med 2008, 44:1887-1896. 10.1016/j.freeradbiomed.2008.03.006, 18395528.
15. Balazy M. Trans-arachidonic acids: new mediators of inflammation. J Physiol Pharmacol 2000, 51(4 Pt 1):597-607.
16. Das UN. Molecular Basis of Health and Disease 2011, New York: Springer.
17. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037. 10.1084/jem.20020760, 2194036, 12391014.
18. Macdonald LJ, Boddy SC, Denison FC, Sales KJ, Jabbour HN. A role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium. Reproduction 2011, 142:345-352. 10.1530/REP-11-0021, 3139491, 21555360.
19. Das UN. Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4. Prostaglandins Leukot Essent Fatty Acids 2012, 86:3-11. 10.1016/j.plefa.2011.09.008, 22014542.
20. Mayer K, Schmidt R, Muhly-Reinholz M, Bogeholz T, Gokorsch S, Grimminger F, Seeger W. In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFα impact of ω-3 versus ω-6 fatty acids. J Lipid Res 2002, 43:944-951.
21. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455.
22. Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, Bonventre JV. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006, 177:5902-5911.
23. Chiang N, Fredman G, Bached F, Oh SF, Vickery T, Schmidt BA, Serhan CN. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012, 484:524-529. 10.1038/nature11042, 3340015, 22538616.
24. Ereso AQ, Cureton EL, Cripps MW, Sadjadi J, Dua MM, Curran B, Victorino GP. Lipoxin A4 attenuates microvascular fluid leak during inflammation. J Surg Res 2009, 156:183-188. 10.1016/j.jss.2009.01.009, 2946836, 19524267.
25. Walker J, Dichter E, Lacorte G, Kerner D, Spur B, Rodriguez A, Yin K. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 2011, 36:410-416. 10.1097/SHK.0b013e31822798c1, 21701419.
26. Das UN. Is sepsis a pro-resolution deficiency disorder?. Med Hypotheses 2013, 80:297-299. 10.1016/j.mehy.2012.12.007, 23273709.
27. Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, Akhtar SR, Ruzinski JT, Caldwell E, Curtis JR, Heyland DK, Watkins TR, Parsons PE, Martin JM, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011, 39:1655-1662. 10.1097/CCM.0b013e318218669d, 3125670, 21423000.